SFS
ORMP icon

Sowell Financial Services’s Oramed Pharmaceuticals ORMP Stock Holding History

Sowell Financial Services’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,757
Closed -$19K – 2041
2021
Q1 		$19K Buy
1,757
+529
+43% +$4.34K ﹤0.01% 2078
2020
Q4 		$5K Buy
1,228
+30
+3% +$98 ﹤0.01% 2286
2020
Q3 		$3K Buy
1,198
+165
+16% +$575 ﹤0.01% 2150
2020
Q2 		$4K Buy
1,033
+62
+6% +$208 ﹤0.01% 1980
2020
Q1 		$3K Buy
971
+322
+50% +$1.41K ﹤0.01% 2002
2019
Q4 		$3K Buy
649
+521
+407% +$1.95K ﹤0.01% 2087
2019
Q3 		$0 Buy
+128
New +$426 ﹤0.01% 2434

Other funds holding ORMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

Sowell Financial Services's ORMP Position: Q2 2021 in Review

Sowell Financial Services sold out of Oramed Pharmaceuticals (ORMP) in Q2 2021, closing a stake of 1,757 shares — an estimated $19K sold.

Sowell Financial Services first reported a position in ORMP in Q3 2019 and held it in 7 quarters. The position peaked at $19K in Q1 2021. 75 funds tracked by Wall St. Rank hold ORMP as of Q2 2021.

  • Sowell Financial Services reported no remaining Oramed Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,757 Oramed Pharmaceuticals shares in Q2 2021, an estimated $19K.
  • Sowell Financial Services first reported a position in Oramed Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Oramed Pharmaceuticals position peaked at $19K in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.